PALOMBA, GRAZIA
 Distribuzione geografica
Continente #
AS - Asia 2.132
NA - Nord America 1.346
EU - Europa 742
SA - Sud America 414
Continente sconosciuto - Info sul continente non disponibili 66
AF - Africa 35
OC - Oceania 3
Totale 4.738
Nazione #
US - Stati Uniti d'America 1.264
SG - Singapore 847
CN - Cina 467
IT - Italia 340
BR - Brasile 325
HK - Hong Kong 232
VN - Vietnam 192
FR - Francia 117
JP - Giappone 98
NL - Olanda 91
BD - Bangladesh 77
KR - Corea 70
IN - India 49
GB - Regno Unito 39
CA - Canada 36
DE - Germania 35
AR - Argentina 24
CO - Colombia 22
ID - Indonesia 21
FI - Finlandia 19
EC - Ecuador 15
MX - Messico 15
PL - Polonia 15
ZA - Sudafrica 13
AT - Austria 12
IE - Irlanda 12
IL - Israele 12
CZ - Repubblica Ceca 8
ES - Italia 8
PK - Pakistan 8
SA - Arabia Saudita 8
TR - Turchia 8
VE - Venezuela 8
IQ - Iraq 7
UA - Ucraina 7
JM - Giamaica 6
KE - Kenya 6
PH - Filippine 6
RU - Federazione Russa 6
UY - Uruguay 6
MA - Marocco 5
SC - Seychelles 5
AL - Albania 4
CR - Costa Rica 4
HN - Honduras 4
PE - Perù 4
PY - Paraguay 4
SE - Svezia 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
CL - Cile 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GT - Guatemala 3
HU - Ungheria 3
LT - Lituania 3
MY - Malesia 3
NP - Nepal 3
PT - Portogallo 3
TN - Tunisia 3
AM - Armenia 2
BB - Barbados 2
BE - Belgio 2
BO - Bolivia 2
CH - Svizzera 2
CY - Cipro 2
MM - Myanmar 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CU - Cuba 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
Totale 4.672
Città #
Singapore 505
Santa Clara 269
Hong Kong 229
San Jose 175
Hefei 165
Lauterbourg 93
Beijing 87
Ashburn 85
Tokyo 83
Ho Chi Minh City 73
Seoul 70
Dallas 66
Los Angeles 61
Hanoi 52
Cavallino 34
São Paulo 31
New York 27
Milan 22
Genoa 21
San Gregorio di Catania 21
Rome 19
Brooklyn 13
Sala Baganza 13
Cagliari 12
Amsterdam 11
Buffalo 11
Guangzhou 11
Helsinki 11
Minamishinagawa 11
Montreal 11
Rio de Janeiro 11
Chicago 10
Dublin 10
Orem 10
Sassari 10
Council Bluffs 9
Düsseldorf 9
Frankfurt am Main 9
Porto Alegre 9
Vienna 9
Warsaw 9
Bogotá 8
Da Nang 8
Phoenix 8
Turin 8
Bengaluru 7
Boardman 7
Charlotte 7
Chennai 7
Curitiba 7
Dhaka 7
Mumbai 7
Naples 7
Nuremberg 7
Salvador 7
Toronto 7
Boston 6
Florence 6
Houston 6
Hải Dương 6
Johannesburg 6
Manchester 6
Bari 5
Brasília 5
Catania 5
Jacksonville 5
Jakarta 5
Las Vegas 5
Memphis 5
Mexico City 5
Montevideo 5
Perugia 5
Prague 5
San Francisco 5
Winnipeg 5
Belo Horizonte 4
Biên Hòa 4
Buenos Aires 4
Campinas 4
Chandigarh 4
Charleston 4
Denver 4
Fortaleza 4
Guayaquil 4
Haiphong 4
Indianapolis 4
Jackson 4
Lahore 4
Lappeenranta 4
Madrid 4
Miami 4
Nairobi 4
Philadelphia 4
Queens 4
Quito 4
Quảng Ngãi 4
Riyadh 4
San Antonio 4
Springfield 4
St Louis 4
Totale 2.707
Nome #
Four years of activity of the Melanoma Unit of Sassari across North Sardinia 120
Genome-wide association study of susceptibility loci for breast cancer in Sardinian population 94
Antidiabetic potential of vanadium complexes combined with olive leaf extracts: a viable approach to reduce metal toxicity 91
Il CSCC: aspetti distintivi della patologia 87
Germline and somatic NGS-based analysis on BRCA-related tumors 86
Progetto Alternanza scuola lavoro 2016 - Liceo Scientifico G.Marconi di Sassari 85
Triple-negative breast cancer frequency and type of BRCA mutation: Clues from Sardinia 83
Combination of mutations in genes controlling DNA repair and high mutational load plays a prognostic role in pancreatic ductal adenocarcinoma (PDAC): a retrospective real-life study in Sardinian population 83
Heterogeneous prevalence of mutations in KRAS, BRAF, and PIK3CA genes among Sardinian patients with colorectal carcinoma 82
Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe (R) Panel 76
Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients 73
Liquid biopsy in clinical oncology 73
Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective 72
A role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian population 69
nalysis of Fanconi anemia genes in colorectal cancer. 68
BRAF Mutations and Dysregulation of the MAP Kinase Pathway Associated to Sinonasal Mucosal Melanomas 68
KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors 67
KRAS mutations in non-small cell lung cancer: Translational aspects, current therapies and challenges for future research 66
Mutational status of main oncogenes and microsatellite instability in Sardinian patients with advanced colorectal cancer 66
Disease progression and overall survival in Sardinian patients with colorectal cancer according to the kras mutational status 65
Genetic Instability Markers in Cancer 65
Epidemiology and Genetic Susceptibility of Breast and Ovarian Cancer in Sardinian Population 64
Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study 64
BRAF testing techniques in the management of patients with advanced malignant melanoma: a real world comparative study 63
Association studies of candidate genes for Alzheimer's disease in a North Sardinian population. 59
Prevalence of BRCA1 and BRCA2 mutations in Sardinia. 56
Mutations in main candidate genes (egfr, kras, braf) among patients with non-small-cell lung cancer from Sardinia 55
EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma 55
Liquid biopsy-driven Cetuximab rechallenge strategy in molecularly selected metastatic colorectal cancer patients 55
Different pathogenetic mechanisms are underlying molecular alterations in fanconi and mismatch DNA repair genes among patients with colorectal carcinoma 54
Comparison of BRAF testing techniques in patients with advanced malignant melanoma: a real-life study. 54
Assessment of germline and somatic alterations in main candidate genes among patients with multiple primary melanoma 50
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) 50
Prevalence of BRCA1 and BRCA2 mutations in Sardinia 49
May genetic background affect the incidence rates of somatic mutations in KRAS, BRAF, and PIK3CA genes among patients with colorectal carcinoma? Clues from Sardinian population 48
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach 48
A novel spontaneous missense mutation in VMD2 gene is a cause of a Best macular distrophy sporadic case 45
Breast Nodular Fasciitis: A Comprehensive Review 44
BRCA1 and BRCA2 germline mutations in Sardinian breast cancer families and their implications for genetic counseling 43
Prevalence of EGFR, KRAS and BRAF mutations among patients with non-small-cell lung cancer from Sardinia 42
ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy 42
Comparison of multiple tumor lesions from the same melanoma patients using next-generation sequencing (NGS) approaches 41
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: A population-based study 40
Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma 40
Female Adnexal Tumors of probable Wolffian Origin (FATWO): a case series with next-generation sequencing mutation analysis 40
Mutation analysis of known candidate genes and evaluation of protein expression through proteomic approaches in malignant melanoma 38
Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma 38
Analisi di geni candidati nella malattia di Alzheimer in Sardegna. 38
Analyses of key-regulator genes in melanoma susceptibility and pathogenesis among patients from south Italy. 37
Impact of tissue type and content of neoplastic cells in the specimen on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma. 37
Heterogeneous prevalence of somatic mutations in KRAS, BRAF, and PIK3CA genes among patients with colorectal carcinoma: clues from Sardinia 37
KRAS mutational concordance between primary and metastatic colorectal adenocarcinoma 37
A novel candidate gene in human endometrial cancer at chromosome 10q26 37
Long non-coding RNA CASC2 in human cancer 37
Identification of predictive factors for the occurrence of predisposing MLH1 and MSH2 germline mutations among Sardinian patients with colorectal carcinoma 36
Epidemiology of ovarian cancer in North Sardinia, Italy, during the period 1992-2010 36
Role of the EGF +61A>G polymorphism in melanoma pathogenesis: an experience on a large series of Italian cases and controls. 35
Identification of a founder BRCA2 mutation in Sardinia 35
Molecular alterations at chromosome 9p21 in melanocytic nevi and melanoma. 35
BRCA1 and BRCA2 mutation analysis in breast cancer families from Sardinia 34
BRCA1 and BRCA2 analysis in Sardinian breast cancer families 34
Molecular classification for the management of melanoma patients. 33
Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy 33
BRAF-NRAS mutation analysis among primary tumors and metastases at different sites from patients with melanoma 32
BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland 32
Sequential accumulation of molecular alterations at the chromosome 9p21 during development and progression of melanoma. 31
Estratto fenolico di bacche di mirto comune e composizione farmaceutica orale contenente il suddetto estratto in combinazione con un complesso di vanadio 31
Cytogenetic analysis at chromosome 9p21 on tissue sections from patients with malignant melanoma 31
Fanconi genes may contribute to melanoma pathogenesis. 30
Heterogeneous prevalence of KRAS, BRAF, and PIK3CA mutations in patients with colorectal carcinoma from Sardinia 30
Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia 30
Distribution of BRCA1 and BRCA2 mutations in Sardinia. 30
Toward the characterization of a genetic profile with prognostic value at CDKN2A locus in melanoma patients. 30
Impact of tissue type and content of neoplastic cells in the specimen on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma. 30
Fanconi genes are altered in subsets of patients with sporadic colorectal carcinoma. 29
Genetic and epigenetic alterations of mismatch repair genes in endometrial and colorectal carcinomas 29
A pattern of polymorphic variants at the CDKN2 locus is associated with both susceptibility and prognosis in melanoma patients. 28
Linkage analysis on Alzheimer's disease candidate genes in a Sardinian population. 28
Origin and distribution of the BRCA2-8765delAG mutation in breast cancer 28
Germline mutations in candidate genes among patients with cutaneous melanoma from Sardinia. 28
Role of the Fanconi gene pathway into the pathogenesis of melanoma. 28
The EGF 61A>G polymorphism has no role in nevi formation and melanoma pathogenesis within italian population 28
BRCA1 and BRCA2 mutation analysis through an evaluation clinic program among Sardinian breast cancer patients. 28
A founder mutation in Sardinian brest cancer families detected by identity-by-descent method 28
Mutation analysis of HMLH1-HMSH2 genes among Sardinian patients with sporadic and familial colorectal cancer 28
Squamous cell carcinoma arising in mature cystic teratoma of the ovary: Report of two cases with molecular analysis 27
Progressive alterations at chromosome 9P21 in melanomagenesis 27
CASC2a gene is downregulated in endometrial cancer. 27
Role of CASC2 a gene in human endometrial cancer. 27
Identification of a novel candidate gene, MENC, in a consensus region of allelic deletion at chromosome 10q26 in human endometrial cancer. 27
Downregulation of the CASC2a gene in endometrial cancer. 27
Assessment of germline and somatic alterations in main candidate genes among patients with multiple primary melanoma. 27
Mutation prevalence for candidate genes varies in melanoma population from south Italy. 27
Primary dermal melanoma in a patient with a history of multiple malignancies: a case report with molecular characterization. 26
Distribution of the BRCA2-8765delAG mutation in breast cancer in mediterranean area. 26
Germline mutations of hMSH2 and hMLH1 genes in Sardinian patients with colorectal cancer 25
Role of Fanconi, MAPK, and p16CDKN2A gene pathways into the pathogenesis of melanoma. 25
Role of BRCA2 mutation status on overall survival among breast cancer patients from Sardinia 25
Germline mutations in Brca1 and Brca2 genes among Sardinian breast cancer patients 24
Spectrum and prevalence of BRCA1 and BRCA2 germline mutations in Sardinian breast cancer patients through a hospital-based screening. 23
Totale 4.524
Categoria #
all - tutte 16.329
article - articoli 11.797
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 698
Totale 28.824


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202424 0 0 0 0 0 0 0 0 2 0 12 10
2024/20251.510 20 7 95 55 277 54 31 79 50 103 395 344
2025/20262.640 130 235 282 327 401 132 390 163 180 192 99 109
2026/2027564 135 115 314 0 0 0 0 0 0 0 0 0
Totale 4.738